<DOC>
	<DOCNO>NCT00177008</DOCNO>
	<brief_summary>This study determine efficacy medication switch Aripiprazole treatment schizophrenia schizoaffective disorder patient moderate high symptom social anxiety . Specifically study test possibility medication switch Aripiprazole reduce symptom social anxiety patient population .</brief_summary>
	<brief_title>Aripiprazole Treatment Schizophrenia With Co-Morbid Social Anxiety</brief_title>
	<detailed_description>Although research show social anxiety common among patient suffer schizophrenia schizoaffective disorder , rarely diagnose treat patient population . This study determine efficacy medication switch Aripiprazole treatment schizophrenia patient moderate high symptom social anxiety . Specifically study test possibility medication switch Aripiprazole reduce symptom social anxiety patient population . In addition , study test possibility Aripiprazole significantly improve social adjustment , quality life level function patient . The study may also assess ability Aripiprazole reduce sexual dysfunction .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Inclusion Criteria 1 . Patients meet DSM IV diagnostic criterion schizophrenia schizoaffective disorder . 2 . Patients present comorbid social anxiety symptom moderate high severity eligible participation study . Only patient LSAS score 30* qualify study . 3 . Age 1865 4 . Gender : male females 5 . Females : nonpregnant , childbearing potential ; childbearing age must contraceptive pill shot ( condom alone sufficient ) 6 . Good general health 1 . Patient meet DSM IV diagnostic criterion schizophrenia schizoaffective disorder 2 . Patient carry diagnosis dementia , degenerative CNS disorder , mental retardation , substance abuse dependence nicotine dependence alcohol abuse exclude study . 3 . Patients acute medical condition eligible . 4 . Patients allergic otherwise intolerant nonresponsive Aripiprazole 5 . Patient history suicidal , homicidal assaultive plan attempt past 6 month . 6 . Clinically significant EKG lab abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective Disorder</keyword>
	<keyword>Social Anxiety Disorder</keyword>
</DOC>